ITHACA — Rheonix, Inc., an Ithaca–based microfluidics company, today announced the addition of Frank Gill as vice president of manufacturing.
Gill will be responsible for formulating and executing the company’s operations strategy as it scales from prototype volumes to fully-automated production of life science and in-vitro diagnostics products, the company said in a news release.
Gill will oversee manufacturing of Rheonix-instrument platforms, reagent kits, and the Rheonix CARD system, an automated-microfluidic platform capable of analyzing raw samples in a variety of applications, the company said.
(Sponsored)
Year-End Benefits Check: Is Your Team Getting the BOOST They Deserve for 2026?
As we close out 2025 and finalize employee benefits for the coming year, there’s one question every small to medium-sized business owner should ask: Are your employees truly understanding—and maximizing—the
What Is Governance, Risk Management, and Compliance (GRC)?
As cyber threats grow in numbers and severity, regulatory bodies are developing new cybersecurity frameworks for businesses to adhere to. These frameworks vary by industry, and a new type of
Most recently, Gill served as director of reagent-manufacturing operations at 454 Life Sciences, a division of the Switzerland–based Roche Group.
Contact Reinhardt at ereinhardt@cnybj.com
